Clinical value of hs-CRP and BNP detection in the diagnosis and treatment of COPD patients with pulmonary heart disease
10.3760/cma.j.issn.1008-6706.2019.12.005
- VernacularTitle: 超敏C反应蛋白及B型脑钠肽检测在慢性阻塞性肺疾病合并肺心病诊疗中的应用价值
- Author:
Guilian WEI
1
;
Zeli ZHANG
Author Information
1. Department of Respiration, the Fifth People's Hospital of Datong, Datong, Shanxi 037009, China
- Publication Type:Journal Article
- Keywords:
Pulmonary disease, chronic obstructive;
C-reactive protein;
Natriuretic peptide, brain;
Pulmonary heart disease;
Ventricular function;
Heart failure
- From:
Chinese Journal of Primary Medicine and Pharmacy
2019;26(12):1429-1432
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the application value of hs-CRP and BNP detection in COPD patients with pulmonary heart disease.
Methods:From January 2016 to January 2018, 80 patients with COPD in the Fifth People's Hospital of Datong were selected.Forty-two COPD patients complicated with pulmonary heart disease were selected as COPD and cor pulmonale group, 38 COPD patients without pulmonary heart disease were selected as COPD group, and 30 healthy volunteers were selected as control group.The differences of hs-CRP and BNP levels were compared, and the diagnostic value of hs-CRP and BNP for COPD combined with pulmonary heart disease was analyzed.
Results:There were statistically significant differences in hs-CRP[(72.5±20.4) mg/L vs.(37.5±9.8) mg/L vs.(3.7±1.2)mg/L], BNP[(362.8±86.9) ng/L vs.(125.9±34.8) ng/L vs.(28.5±9.9)ng/L] among the COPD and cor pulmonale group, COPD group and control group (F=9.245, 14.668, all P<0.05). The hs-CRP and BNP levels in the COPD and cor pulmonale group were significantly higher than those in the other two groups(t=19.294, 11.576, 21.385, 9.258, 9.258, all P<0.05), which of the COPD group were significantly higher than those of the control group (t=8.912, 12.567, all P<0.05). The best boundary value of BNP in diagnosis of COPD with cor pulmonale was 261.8ng/L, and its diagnostic sensitivity and specificity were 96.2% and 85.4%, respectively, the area under the line was 0.834, which were all higher than those of hs-CRP.With the increase of cardiac function, the levels of hs-CRP[(38.5±10.3) mg/L vs.(51.4±14.8) mg/L vs.(75.1±21.5) mg/L vs.(93.7±31.8)mg/L], BNP[(142.8±56.5) ng/L vs.(285.9±94.8) ng/L vs.(352.5±118.2) ng/L vs.(478.5±130.3)ng/L] increased, the differences were statistically significant (F=13.577, 16.776, all P<0.05). There were significant correlation between hs-CRP, BNP levels and COPD patients complicated with cor pulmonale (r=0.675, 0.766, all P<0.05).
Conclusion:hs-CRP and BNP have high diagnostic potency for COPD patients combined with cor pulmonale, and are positively correlated with cardiac function classification.
